Title : Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma.

Pub. Date : 2018 Nov

PMID : 30311444






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Taken together, our study demonstrates that SESN2 activates AKT and AMPK signaling as a novel mechanism to induce sorafenib primary resistance in HCC. Sorafenib AKT serine/threonine kinase 1 Homo sapiens